Anfirma NV has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anfima NV, one of the promoters of Camlin Fine Sciences, has filed an annual declaration with the stock exchanges under Regulation 31(4) of the SEBI Takeover Regulations. The declaration confirms that Anfima NV has not created any new encumbrance (such as pledge or lien) on the shares of the company held by them, directly or indirectly, during the financial year ended March 31, 2024, beyond what was already disclosed. The filing is addressed to BSE, NSE, and the company's Audit Committee. It is a routine annual compliance submission with no new financial action being taken.
This is a routine regulatory filing and is mildly reassuring for shareholders as it confirms the promoter has not pledged or encumbered any additional shares. No material impact on stock price is expected from this disclosure.